Anti-neoplastic activity of C205: a new topical anti-cancer formulation

Area of Science:

• Oncology
• Pharmacology
• Drug Development

Background:

• Topical drug delivery offers targeted treatment for skin and subcutaneous tumors.
• Evaluating the efficacy of novel topical anti-neoplastic agents is crucial for clinical advancement.

Purpose of the Study:

• To assess the anti-tumor efficacy of C205, a novel topical ointment, in preclinical cancer models.
• To compare the anti-neoplastic activity of C205 with a standard chemotherapy agent, 5-fluorouracil.

Main Methods:

• Utilized a subcutaneous B-16 melanoma model to evaluate topical drug activity.
• Assessed tumor growth inhibition using the T/C ratio (Tumor size in treated vs. control animals).
• Evaluated anti-tumor activity against Lewis lung carcinoma models.

Main Results:

• C205 achieved a T/C ratio of 14 in B-16 melanoma models.
• 50% of animals treated with C205 showed no viable tumor at 60 days post-treatment.
• C205 exhibited superior anti-neoplastic activity compared to 5-fluorouracil and demonstrated efficacy against Lewis lung carcinoma with minimal weight loss.

Conclusions:

• C205 possesses significant topical anti-tumor activity against melanoma and Lewis lung carcinoma.
• The efficacy of C205 suggests its potential as a novel therapeutic agent for specific cancer types.
• Further clinical investigation of C205 is warranted based on its promising preclinical results.